Financials

  • Market Capitalization 265.28 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.23
Relación precio/flujo de caja
7.96

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3439
ELDN
Eledon Pharmaceuticals, Inc. - Common Stock
3.32 USD-0.90%-6.21%-2.64%+29.18%269.79 M USD
3445
ALEC
Alector, Inc. - Common Stock
2.39 USD-2.85%+3.91%+58.28%0.00%266.86 M USD
3456
CGEN
Compugen Ltd. - Ordinary Shares
2.76 USD-2.82%+4.55%+21.05%+97.14%260.97 M USD
3460
MGNX
MacroGenics, Inc. - Common Stock
4.08 USD+0.99%-0.24%+6.25%+137.21%259.90 M USD

Noticias